相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolic functions of the tumor suppressor p53: Implications in normal physiology, metabolic disorders, and cancer
Matthieu Lacroix et al.
MOLECULAR METABOLISM (2020)
Current issues and perspectives in PD-1 blockade cancer immunotherapy
Kenji Chamoto et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)
P53 and The Immune Response: 40 Years of Exploration-A Plan for the Future
Arnold J. Levine
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Cancer-Specific Loss of p53 Leads to a Modulation of Myeloid and T Cell Responses
Julianne Blagih et al.
CELL REPORTS (2020)
Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers
Parisa Malekzadeh et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Neoantigen-directed immune escape in lung cancer evolution
Rachel Rosenthal et al.
NATURE (2019)
Regulatory T cells in cancer immunosuppression - implications for anticancer therapy
Yosuke Togashi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Natural killer cells limit the clearance of senescent lung adenocarcinoma cells
Kate L. Stokes et al.
ONCOGENESIS (2019)
Neutrophils Driving Unconventional T Cells Mediate Resistance against Murine Sarcomas and Selected Human Tumors
Andrea Ponzetta et al.
CELL (2019)
Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis
Max D. Wellenstein et al.
NATURE (2019)
Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer
Alberto A. Chiappori et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Neutrophil-induced genomic instability impedes resolution of inflammation and wound healing
Veronika Butin-Israeli et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Cancer-Associated Mutations but No Cancer: Insights into the Early Steps of Carcinogenesis and Implications for Early Cancer Detection
Scott R. Kennedy et al.
TRENDS IN CANCER (2019)
Control of metabolism by p53-Cancer and beyond
Christiaan F. Labuschagne et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
Frederick Arce Vargas et al.
CANCER CELL (2018)
p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy
Nicola R. Hardwick et al.
CLINICAL CANCER RESEARCH (2018)
TP53, STK11, and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti-PD-1 in Lung Adenocarcinoma
Jerome Biton et al.
CLINICAL CANCER RESEARCH (2018)
p53: emerging roles in stem cells, development and beyond
Abhinav K. Jain et al.
DEVELOPMENT (2018)
Activation of p53 in Immature Myeloid Precursor Cells Controls Differentiation into Ly6c+CD103+ Monocytic Antigen-Presenting Cells in Tumors
Madhav D. Sharma et al.
IMMUNITY (2018)
Mechanisms and functions of cellular senescence
Nicolas Herranz et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Hallmarks of Cellular Senescence
Alejandra Hernandez-Segura et al.
TRENDS IN CELL BIOLOGY (2018)
Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246
Tomer Cooks et al.
NATURE COMMUNICATIONS (2018)
CSF1R+ Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype
Juliana B. Candido et al.
CELL REPORTS (2018)
Monocytes Differentiate to Immune Suppressive Precursors of Metastasis-Associated Macrophages in Mouse Models of Metastatic Breast Cancer
Takanori Kitamura et al.
FRONTIERS IN IMMUNOLOGY (2018)
CD24-p53 axis suppresses diethylnitrosamine-induced hepatocellular carcinogenesis by sustaining intrahepatic macrophages
Dongling Li et al.
CELL DISCOVERY (2018)
Phenotype of p53 wild-type epitope-specific T cells in the circulation of patients with head and neck cancer
Andreas E. Albers et al.
SCIENTIFIC REPORTS (2018)
Targeting macrophages: therapeutic approaches in cancer
Luca Cassetta et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment
Chunmei Fu et al.
FRONTIERS IN IMMUNOLOGY (2018)
The diverse functions of the PD1 inhibitory pathway
Arlene H. Sharpe et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Mutant p53 partners in crime
Michael P. Kim et al.
CELL DEATH AND DIFFERENTIATION (2018)
p53-mediated adaptation to serine starvation is retained by a common tumour-derived mutant
Timothy J. Humpton et al.
CANCER & METABOLISM (2018)
Deconstructing networks of p53-mediated tumor suppression in vivo
Alyssa M. Kaiser et al.
CELL DEATH AND DIFFERENTIATION (2018)
Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma
Zhong-Yi Dong et al.
CLINICAL CANCER RESEARCH (2017)
Tumor-associated mutant p53 promotes cancer cell survival upon glutamine deprivation through p21 induction
T. Q. Tran et al.
ONCOGENE (2017)
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
Matthew A. Coelho et al.
IMMUNITY (2017)
Control mechanisms in germ cells mediated by p53 family proteins
Jakob Gebel et al.
JOURNAL OF CELL SCIENCE (2017)
Mutant p53 shapes the enhancer landscape of cancer cells in response to chronic immune signaling
Homa Rahnamoun et al.
NATURE COMMUNICATIONS (2017)
Myc Cooperates with Ras by Programming Inflammation and Immune Suppression
Roderik M. Kortlever et al.
CELL (2017)
Putting p53 in Context
Edward R. Kastenhuber et al.
CELL (2017)
Local Activation of p53 in the Tumor Microenvironment Overcomes Immune Suppression and Enhances Antitumor Immunity
Gang Guo et al.
CANCER RESEARCH (2017)
PDL1 Regulation by p53 via miR-34
Maria Angelica Cortez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
PDL1 Regulation by p53 via miR-34
Maria Angelica Cortez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Long story short: p53 mediates innate immunity
Jessica Miciak et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2016)
CRISPR/Cas9-Mediated Trp53 and Brca2 Knockout to Generate Improved Murine Models of Ovarian High-Grade Serous Carcinoma
Josephine Walton et al.
CANCER RESEARCH (2016)
Lack of p53 Augments Antitumor Functions in Cytolytic T Cells
Anirban Banerjee et al.
CANCER RESEARCH (2016)
Loss of P53 Function Activates JAK2-STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival
Sonja M. Woermann et al.
GASTROENTEROLOGY (2016)
Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 status
Yoon Jin Cha et al.
LUNG CANCER (2016)
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte et al.
NATURE COMMUNICATIONS (2016)
Ligand dependent restoration of human TLR3 signaling and death in p53 mutant cells
Daniel Menendez et al.
ONCOTARGET (2016)
Hypoxia-induced p53 modulates both apoptosis and radiosensitivity via AKT
Katarzyna B. Leszczynska et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
p53 in survival, death and metabolic health: a lifeguard with a licence to kill
Flore Kruiswijk et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2
Dawid G. Nowak et al.
CANCER DISCOVERY (2015)
p53 amplifies Toll-like receptor 5 response in human primary and cancer cells through interaction with multiple signal transduction pathways
Maria Shatz et al.
ONCOTARGET (2015)
A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer
Eveline M. Dijkgraaf et al.
ONCOTARGET (2015)
p53-dependent expression of CXCR5 chemokine receptor in MCF-7 breast cancer cells
Nikita A. Mitkin et al.
SCIENTIFIC REPORTS (2015)
p53 in the Myeloid Lineage Modulates an Inflammatory Microenvironment Limiting Initiation and Invasion of Intestinal Tumors
Xue-Yan He et al.
CELL REPORTS (2015)
A unique role for p53 in the regulation of M2 macrophage polarization
L. Li et al.
CELL DEATH AND DIFFERENTIATION (2015)
NKG2D signaling in cancer immunosurveillance
Alejandro Lopez-Soto et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Mutant p53 gains new function in promoting inflammatory signals by repression of the secreted interleukin-1 receptor antagonist
V. Ubertini et al.
ONCOGENE (2015)
Primed for cancer: Li Fraumeni Syndrome and the pre-cancerous niche
Pan Pantziarka
ECANCERMEDICALSCIENCE (2015)
p53 and NF-κB Coregulate Proinflammatory Gene Responses in Human Macrophages
Julie M. Lowe et al.
CANCER RESEARCH (2014)
CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models
Yu Zhu et al.
CANCER RESEARCH (2014)
Downmodulation of Tumor Suppressor p53 by T Cell Receptor Signaling Is Critical for Antigen-Specific CD4+ T Cell Responses
Masashi Watanabe et al.
IMMUNITY (2014)
Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer
Diletta Di Mitri et al.
NATURE (2014)
p53 regulates mesenchymal stem cell-mediated tumor suppression in a tumor microenvironment through immune modulation
Y. Huang et al.
ONCOGENE (2014)
Regulation of NF-κB by TNF family cytokines
Matthew S. Hayden et al.
SEMINARS IN IMMUNOLOGY (2014)
Pathways of Antigen Processing
Janice S. Blum et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Mutant p53 Prolongs NF-κB Activation and Promotes Chronic Inflammation and Inflammation-Associated Colorectal Cancer
Tomer Cooks et al.
CANCER CELL (2013)
Trp53 Inactivation in the Tumor Microenvironment Promotes Tumor Progression by Expanding the Immunosuppressive Lymphoid-like Stromal Network
Gang Guo et al.
CANCER RESEARCH (2013)
Non-Cell-Autonomous Tumor Suppression by p53
Amaia Lujambio et al.
CELL (2013)
The Role of Polymorphonuclear Leukocyte Trafficking in the Perpetuation of Inflammation During Inflammatory Bowel Disease
Jennifer C. Brazil et al.
INFLAMMATORY BOWEL DISEASES (2013)
p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells
Alexandre Iannello et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Tumor Suppressor p53 Inhibits Systemic Autoimmune Diseases by Inducing Regulatory T Cells
Hirotoshi Kawashima et al.
JOURNAL OF IMMUNOLOGY (2013)
MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells
Patrizia Leone et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells
Oliver D. K. Maddocks et al.
NATURE (2013)
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Juan Carlos Acosta et al.
NATURE CELL BIOLOGY (2013)
Senescence and aging: the critical roles of p53
A. Rufini et al.
ONCOGENE (2013)
p53 increases MHC class I expression by upregulating the endoplasmic reticulum aminopeptidase ERAP1
Bei Wang et al.
NATURE COMMUNICATIONS (2013)
Interleukin-1β Promotes Ovarian Tumorigenesis through a p53/NF-κB-Mediated Inflammatory Response in Stromal Fibroblasts
Isaiah Gregory Schauer et al.
NEOPLASIA (2013)
Tumor Suppressive MicroRNAs miR-34a/c Control Cancer Cell Expression of ULBP2, a Stress-Induced Ligand of the Natural Killer Cell Receptor NKG2D
Anja Heinemann et al.
CANCER RESEARCH (2012)
The Human TLR Innate Immune Gene Family Is Differentially Influenced by DNA Stress and p53 Status in Cancer Cells
Maria Shatz et al.
CANCER RESEARCH (2012)
CCR2-Dependent Recruitment of Macrophages by Tumor-Educated Mesenchymal Stromal Cells Promotes Tumor Development and Is Mimicked by TNFα
Guangwen Ren et al.
CELL STEM CELL (2012)
Mutant p53: one name, many proteins
William A. Freed-Pastor et al.
GENES & DEVELOPMENT (2012)
Long-term clinical and immunological effects of p53-SLP® vaccine in patients with ovarian cancer
Ninke Leffers et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: A single-arm phase II study
Renee Vermeij et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Human NK Cells Are Alerted to Induction of p53 in Cancer Cells by Upregulation of the NKG2D Ligands ULBP1 and ULBP2
Sonja Textor et al.
CANCER RESEARCH (2011)
Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2
Hai Li et al.
CELL CYCLE (2011)
Trp53 negatively regulates autoimmunity via the STAT3-Th17 axis
Shuzhong Zhang et al.
FASEB JOURNAL (2011)
p53 Status in Stromal Fibroblasts Modulates Tumor Growth in an SDF1-Dependent Manner
Yoseph Addadi et al.
CANCER RESEARCH (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Hallmarks of cancer: Interactions with the tumor stroma
Kristian Pietras et al.
EXPERIMENTAL CELL RESEARCH (2010)
B Cells Are Required for Optimal CD4+ and CD8+ T Cell Tumor Immunity: Therapeutic B Cell Depletion Enhances B16 Melanoma Growth in Mice
David J. DiLillo et al.
JOURNAL OF IMMUNOLOGY (2010)
Pathologies Associated with the p53 Response
Andrei V. Gudkov et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Blinded by the Light: The Growing Complexity of p53
Karen H. Vousden et al.
CELL (2009)
The Macrophage Colony-Stimulating Factor 1 Response Signature in Breast Carcinoma
Andrew H. Beck et al.
CLINICAL CANCER RESEARCH (2009)
Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial
Ninke Leffers et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
SOCS1 Links Cytokine Signaling to p53 and Senescence
Viviane Calabrese et al.
MOLECULAR CELL (2009)
Role of Toll-like receptors in tissue repair and tumorigenesis
S. Rakoff-Nahoum et al.
BIOCHEMISTRY-MOSCOW (2008)
Self-tolerance does not restrict the CD4+T-helper response against the p53 tumor antigen
Marjolein M. Lauwen et al.
CANCER RESEARCH (2008)
Senescence of activated stellate cells limits liver fibrosis
Valery Krizhanovsky et al.
CELL (2008)
Defective MHC class I antigen surface expression promotes cellular survival through elevated ER stress and modulation of p53 function
K. Sabapathy et al.
CELL DEATH AND DIFFERENTIATION (2008)
Activated neutrophils induce an hMSH2-dependent G2/M checkpoint arrest and replication errors at a (CA) 13-repeat in colon epithelial cells
C. Campregher et al.
GUT (2008)
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
Jean-Philippe Coppe et al.
PLOS BIOLOGY (2008)
p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis
A. Ruddell et al.
ONCOGENE (2008)
Breast-cancer stromal cells with TP53 mutations and nodal metastases
Attila Patocs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Alteration of cellular and humoral immunity by mutant p53 protein and processed mutant peptide in head and neck cancer
Marion E. Couch et al.
CLINICAL CANCER RESEARCH (2007)
P53-specific T cell responses in patients with malignant and benign ovarian tumors: Implications for p53 based immunotherapy
Annechien Lambeck et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion
S. A. Mehta et al.
ONCOGENE (2007)
Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium
Yuko Matsumoto et al.
NATURE MEDICINE (2007)
Mutant p53 enhances nuclear factor κB activation by tumor necrosis factor α in cancer cells
Lilach Weisz et al.
CANCER RESEARCH (2007)
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Wen Xue et al.
NATURE (2007)
Tumor-stroma interactions in pancreatic ductal adenocarcinoma
Daruka Mahadevan et al.
MOLECULAR CANCER THERAPEUTICS (2007)
p53 in health and disease
Karen H. Vousden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Policing of oncogene activity by p53
Alejo Efeyan et al.
NATURE (2006)
Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer
V Goodell et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer
SJ Antonia et al.
CLINICAL CANCER RESEARCH (2006)
Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis
R Hill et al.
CELL (2005)
NKG2D function protects the host from tumor initiation
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Role of Stat3 in regulating p53 expression and function
GL Niu et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
ZB Chen et al.
NATURE (2005)
Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation
DR Hodge et al.
CANCER RESEARCH (2005)
Tumor suppressor p53 inhibits autoimmune inflammation and macrophage function
SJ Zheng et al.
DIABETES (2005)
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint
RG Jones et al.
MOLECULAR CELL (2005)
p53 is a suppressor of inflammatory response in mice
EA Komarova et al.
FASEB JOURNAL (2005)
Two distinct pathways of immuno-modulation improve potency of p53 immunization in rejecting established tumors
P Daftarian et al.
CANCER RESEARCH (2004)
CCR5 expression influences the progression of human breast cancer in a p53-dependent manner
S Mañes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting
G Fingerle-Rowson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Mutant p53 in bone marrow stromal cells increases VEGF expression and supports leukemia cell growth
A Narendran et al.
EXPERIMENTAL HEMATOLOGY (2003)
Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence
A Takaoka et al.
NATURE (2003)
Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patients
AG Menon et al.
CANCER GENE THERAPY (2003)
CTLA-4 blockade enhances the therapeutic effect of an attenuated poxvirus vaccine targeting p53 in an established murine tumor model
J Espenschied et al.
JOURNAL OF IMMUNOLOGY (2003)
Regulatory role of p53 in experimental autoimmune encephalomyelitis
Y Okuda et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Nitric oxide-induced cellular stress and p53 activation in chronic inflammation
LJ Hofseth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas
K Kurose et al.
NATURE GENETICS (2002)
p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3
J Lin et al.
ONCOGENE (2002)
Regulation of cutaneous malignancy by γδ T cells
M Girardi et al.
SCIENCE (2001)
Helicobacter pylori infection and the development of gastric cancer.
N Uemura et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran et al.
NATURE (2001)
Generation of T cells specific for the wild-type sequence p53264-272 peptide in cancer patients:: Implications for immunoselection of epitope loss variants
TK Hoffmann et al.
JOURNAL OF IMMUNOLOGY (2000)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
GJ Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
CD4+ T cell responses to self- and mutated p53 determinants during tumorigenesis in mice
EV Fedoseyeva et al.
JOURNAL OF IMMUNOLOGY (2000)
Differential tumor surveillance by natural killer (NK) and NKT cells
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
The use of HLA A2,1/p53 peptide tetramers to visualize the impact of self tolerance on the TCR repertoire
J Hernández et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
